At the Max Rady College of Medicine, University of Manitoba, in Canada, researchers have developed a stem-cell-based therapy that is regenerating spinal cords in laboratory animals and may become available for human clinical trials.
Blocking inhibitory molecules that cause neuronal cells to degenerate, and inhibit stem cell transplants may prove a breakthrough therapy.